GlassScriptPhysician profile
Betty Banh
NPI 1215660394
$4,640.83
in general payments reported to CMS, 2019-2025
39 companies · $1,734 in 2025
The $1,734 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $220 · 2023: $1,397 · 2024: $1,289 · 2025: $1,734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,143 · Education: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,142.74 |
| Education | $278.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $518.54 | 2023-2025 | Pylarify |
| Sumitomo Pharma America, INC. | $487.01 | 2023-2025 | Gemtesa |
| Janssen Biotech, INC. | $406.19 | 2023-2025 | Erleada, Carvykti, Rybrevant |
| Dendreon Pharmaceuticals LLC | $354.79 | 2023-2025 | Provenge |
| Abbvie INC. | $314.65 | 2023-2025 | |
| Blue Earth Diagnostics | $216.03 | 2024-2025 | Posluma |
| Coloplast Corp | $205.72 | 2023-2025 | Speedicath |
| Pfizer INC. | $192.61 | 2023-2025 | |
| Endo USA, INC. | $185.22 | 2024-2025 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $177.94 | 2024-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $157.91 | 2022-2025 | |
| Astellas Pharma US INC | $154.17 | 2025 | Xtandi |
| Axonics, INC. | $109.14 | 2023-2024 | Axonics, Bulkamid |
| Urogen Pharma, INC. | $102.12 | 2024-2025 | |
| Tolmar, INC. | $85.55 | 2023-2025 | Eligard, Jatenzo |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betty Banh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.